When Al was diagnosed with stage 4 pancreatic cancer, his oncologist told him she had never seen a patient with his diagnosis achieve complete remission. The survival rate for this cancer is measured in months.

Those are the odds Al faced before receiving the Immunocine Dendritic Cell Treatment (IDCT) at Immunocine Cancer Center in Cancun.

Prior to receiving the IDCT, Al tried multiple types of chemotherapy and immunotherapy along with surgery to no measurable improvements. He began “to get his affairs in order.”

Upon completion of his treatment, Al quickly noticed an improvement in his health. As of December 2023, his CT scans show no signs of cancer. This chapter of his life that was consumed with pancreatic cancer is now closed.

----------------------------------------------------------------
Interested in exploring Immunocine's revolutionary Cancer Treatment? Learn more at https://immunocine.com/
----------------------------------------------------------------

The Immunocine Cancer Center provides one of the most advanced Cancer Immunotherapies available. Backed by research and multiple clinical trials, the Immunocine Treatment is meant for the cancer patients of today seeking the cancer treatment of tomorrow.